Home › Funds › Employees Provident Fund Board › BSX

Employees Provident Fund Board position in BSX

BOSTON SCIENTIFIC CORP · Health Care

Employees Provident Fund Board reported holding 2,880,000 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q3 2026 13F filing — a position valued at US$125.7M, representing 0.66% of its reported portfolio and ranking #37 among its reported holdings. Employees Provident Fund Board has disclosed BSX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)2.88M sh
Reported value held$125.71M
Portfolio Weight0.66%
First reportedQ4 2024
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Employees Provident Fund Board's BSX position evolved

Employees Provident Fund Board first disclosed a stake in BSX in Q4 2024 at 260,966 shares (US$23.3M). The position peaked in Q2 2025 at 2,007,830 shares, worth US$215.7M. Across 8 filings, Employees Provident Fund Board increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 2,880,000 shares valued at US$125.7M — a reduction of -478,700 shares quarter over quarter.. Notable position changes include a 431% increase in Q1 2025 (shares rose 6% over the following quarter), a 45% increase in Q2 2025 (shares fell 9% over the following quarter), a 57% increase in Q2 2026 (shares rose 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 260.97K $23.31M New
Q1 2025 1.39M $139.88M Add
Q2 2025 2.01M $215.66M Add
Q3 2025 2.13M $208.40M Add
Q4 2025 2.13M $203.53M Hold
Q1 2026 2.13M $133.95M Hold
Q2 2026 3.36M $143.35M Add
Q3 2026 2.88M $125.71M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BSX and 13F data

BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 20 other funds we track also report a position in BSX — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$2.56B), MFS Investment Management (US$2.29B), Arrowstreet Capital (US$1.24B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BSX

All BSX fund holders →

FAQ

How long has Employees Provident Fund Board held BSX?

Employees Provident Fund Board has disclosed BSX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Employees Provident Fund Board's current position in BSX?

As of Q3 2026, Employees Provident Fund Board holds 2.88M shares of BSX (BOSTON SCIENTIFIC CORP), valued at $125.71M, representing 0.66% of its reported portfolio and ranking #37.

Has Employees Provident Fund Board been buying or selling BSX?

In the latest 13F filing (Q3 2026), Employees Provident Fund Board reduced its position in BSX. The position peaked in Q2 2025 at 2.01M shares.

Which other funds hold BSX?

Other major institutional holders of BSX include PRIMECAP MANAGEMENT CO/CA/, MFS Investment Management, Arrowstreet Capital, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.